JP2007507467A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007507467A5 JP2007507467A5 JP2006530264A JP2006530264A JP2007507467A5 JP 2007507467 A5 JP2007507467 A5 JP 2007507467A5 JP 2006530264 A JP2006530264 A JP 2006530264A JP 2006530264 A JP2006530264 A JP 2006530264A JP 2007507467 A5 JP2007507467 A5 JP 2007507467A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- methyl
- salts
- compounds
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 24
- 239000001257 hydrogen Substances 0.000 claims 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 17
- 150000001204 N-oxides Chemical class 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 8
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 5
- 239000005977 Ethylene Substances 0.000 claims 5
- 229910052731 fluorine Chemical group 0.000 claims 4
- 239000011737 fluorine Chemical group 0.000 claims 4
- 229910052736 halogen Chemical group 0.000 claims 3
- 150000002367 halogens Chemical group 0.000 claims 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 0 CC(*)(C=C1)C(*=*C2*C2)=CC=C1C1=Cc(nc(*c2cc(O*)ccn2)[n]2)c2N=CC1(C)* Chemical compound CC(*)(C=C1)C(*=*C2*C2)=CC=C1C1=Cc(nc(*c2cc(O*)ccn2)[n]2)c2N=CC1(C)* 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03022053 | 2003-10-01 | ||
| PCT/EP2004/052378 WO2005030771A1 (en) | 2003-10-01 | 2004-09-30 | Imidazopyridine-derivatives as inductible no-synthase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007507467A JP2007507467A (ja) | 2007-03-29 |
| JP2007507467A5 true JP2007507467A5 (cg-RX-API-DMAC7.html) | 2007-11-15 |
Family
ID=34384571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530264A Withdrawn JP2007507467A (ja) | 2003-10-01 | 2004-09-30 | 誘導性ｎｏシンターゼ阻害剤としてのイミダゾピリジン誘導体 |
Country Status (19)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06003351A (es) * | 2003-10-01 | 2006-06-08 | Altana Pharma Ag | Derivados de imidazopiridina como inhibidores de no-sintasa inducible. |
| KR20060092220A (ko) * | 2003-10-01 | 2006-08-22 | 알타나 파마 아게 | 유도성 ｎｏ-신타아제 저해제로서의 이미다조피리딘 유도체 |
| KR20060092221A (ko) | 2003-10-01 | 2006-08-22 | 알타나 파마 아게 | 유도성 ｎｏ-신타제 억제제로서의이미다조（4,5-ｂ）피리딘 유도체 |
| EP1670798A1 (en) | 2003-10-01 | 2006-06-21 | Altana Pharma AG | Aminopyridine-derivatives as inductible no-synthase inhibitors |
| AR057525A1 (es) * | 2005-10-03 | 2007-12-05 | Astrazeneca Ab | Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion |
| AR055669A1 (es) * | 2005-10-03 | 2007-08-29 | Astrazeneca Ab | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. |
| ES2573412T3 (es) * | 2010-09-10 | 2016-06-07 | Shionogi & Co., Ltd. | Derivado de imidazol de heteroanillo fusionado que tiene efecto de AMPK (activacion de proteina cinasa activada por monofosfato de adenosina) |
| GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4045564A (en) * | 1974-02-18 | 1977-08-30 | Ab Hassle | Benzimidazole derivatives useful as gastric acid secretion inhibitors |
| SE418966B (sv) | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
| GB8307865D0 (en) | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
| SE512835C2 (sv) | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
| AUPP873799A0 (en) | 1999-02-17 | 1999-03-11 | Fujisawa Pharmaceutical Co., Ltd. | Pyridine compounds |
| ATE384722T1 (de) * | 2002-03-27 | 2008-02-15 | Nycomed Gmbh | Alkoxypyridinderivate |
| AU2003280578A1 (en) * | 2002-10-30 | 2004-05-25 | Ajinomoto Co., Inc. | Heterocyclic compounds |
| MXPA06003351A (es) * | 2003-10-01 | 2006-06-08 | Altana Pharma Ag | Derivados de imidazopiridina como inhibidores de no-sintasa inducible. |
| KR20060092220A (ko) * | 2003-10-01 | 2006-08-22 | 알타나 파마 아게 | 유도성 ｎｏ-신타아제 저해제로서의 이미다조피리딘 유도체 |
| KR20060092221A (ko) | 2003-10-01 | 2006-08-22 | 알타나 파마 아게 | 유도성 ｎｏ-신타제 억제제로서의이미다조（4,5-ｂ）피리딘 유도체 |
| BRPI0414873A (pt) | 2003-10-01 | 2006-12-12 | Altana Pharma Ag | derivados de imidazopiridina como inibidores de no-sintase induzìveis |
| EP1670798A1 (en) | 2003-10-01 | 2006-06-21 | Altana Pharma AG | Aminopyridine-derivatives as inductible no-synthase inhibitors |
-
2004
- 2004-09-30 KR KR1020067005873A patent/KR20060092220A/ko not_active Withdrawn
- 2004-09-30 US US10/573,484 patent/US7468377B2/en not_active Expired - Fee Related
- 2004-09-30 WO PCT/EP2004/052378 patent/WO2005030771A1/en not_active Ceased
- 2004-09-30 NZ NZ546437A patent/NZ546437A/en unknown
- 2004-09-30 AT AT04787263T patent/ATE399169T1/de not_active IP Right Cessation
- 2004-09-30 MX MXPA06003349A patent/MXPA06003349A/es not_active Application Discontinuation
- 2004-09-30 AU AU2004276015A patent/AU2004276015A1/en not_active Abandoned
- 2004-09-30 DE DE602004014630T patent/DE602004014630D1/de not_active Expired - Lifetime
- 2004-09-30 RS YUP-2006/0196A patent/RS20060196A/sr unknown
- 2004-09-30 EP EP04787263A patent/EP1675854B1/en not_active Expired - Lifetime
- 2004-09-30 JP JP2006530264A patent/JP2007507467A/ja not_active Withdrawn
- 2004-09-30 CA CA002540083A patent/CA2540083A1/en not_active Abandoned
- 2004-09-30 CN CNB2004800275920A patent/CN100415745C/zh not_active Expired - Fee Related
- 2004-09-30 ES ES04787263T patent/ES2309567T3/es not_active Expired - Lifetime
- 2004-09-30 EA EA200600608A patent/EA010261B1/ru not_active IP Right Cessation
- 2004-09-30 BR BRPI0414972-6A patent/BRPI0414972A/pt not_active IP Right Cessation
-
2006
- 2006-02-23 IL IL173895A patent/IL173895A0/en unknown
- 2006-02-24 ZA ZA200601642A patent/ZA200601642B/en unknown
- 2006-03-24 NO NO20061344A patent/NO20061344L/no not_active Application Discontinuation
-
2008
- 2008-09-26 US US12/232,973 patent/US20090036482A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2006524660A5 (cg-RX-API-DMAC7.html) | ||
| ATE457988T1 (de) | A2a-adenosin-rezeptor-antagonisten | |
| JP2013537203A5 (cg-RX-API-DMAC7.html) | ||
| WO2006098918A3 (en) | Substituted gamma lactams as therapeutic agents | |
| MX2009004900A (es) | Arilamidas sustituidas por tiazol u oxazol. | |
| JP2016503797A5 (cg-RX-API-DMAC7.html) | ||
| JP2010526814A5 (cg-RX-API-DMAC7.html) | ||
| JP2010504286A5 (cg-RX-API-DMAC7.html) | ||
| JP2005539088A5 (cg-RX-API-DMAC7.html) | ||
| RU2012112471A (ru) | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-iv для лечения или предупреждения диабета | |
| NO20084853L (no) | Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni | |
| PE20080360A1 (es) | Derivados 4-bencilftalazinona 2-sustituidos como antagonistas de histaminas h1 y h3 | |
| EA200901573A1 (ru) | Гетероарилзамещенные тиазолы | |
| JP2007520440A5 (cg-RX-API-DMAC7.html) | ||
| JP2007519721A5 (cg-RX-API-DMAC7.html) | ||
| CY1116190T1 (el) | Φαρμακευτικη συνθεση η οποια περιεχει οπτικα ενεργη ενωση που διαθετει δραστικοτητα αγωνιστη υποδοχεα θρομβοποιητινης και ενδιαμεσο γι' αυτην | |
| JP2008513510A5 (cg-RX-API-DMAC7.html) | ||
| ATE507212T1 (de) | Morpholine als 5ht2c-agonisten | |
| JP2009501745A5 (cg-RX-API-DMAC7.html) | ||
| JP2015504917A5 (cg-RX-API-DMAC7.html) | ||
| JP2007507467A5 (cg-RX-API-DMAC7.html) | ||
| JP2010513489A5 (cg-RX-API-DMAC7.html) | ||
| RU2006139140A (ru) | Средства и способы для лечения нарушений свертываемости | |
| JP2016512541A5 (cg-RX-API-DMAC7.html) |